Erectile Impotence and Infertility in Men Undergoing Renal Replacement Therapy
The outlook for patients with end-stage renal disease has improved markedly over the last 30 years as a result of advances in renal replacement therapy. In 1978 data from the European Dialysis and Transplant Registry showed that the prognosis for patients starting dialysis was better than that following myocardial infarction or breast cancer (Wing et al. 1978) and the 10 year survival for adults starting dialysis in the early 1980s can be expected to exceed 65% (Brunner et al 1988). Whilst cardio- and cerebrovascular events caused by premature atherosclerosis are the major causes of death, there is a host of complications to which the end-stage renal disease patient is susceptible which will cause significant morbidity. Sexual dysfunction manifested by loss of libido, reduced fertility and in particular erectile impotence has emerged as a frequent problem in men undergoing renal replacement therapy and this chapter reviews its aetiology, pathophysiology and management.
KeywordsPeritoneal Dialysis Renal Replacement Therapy Sexual Function Sexual Dysfunction Erectile Function
Unable to display preview. Download preview PDF.
- Brook AC, Johnston DG, Ward MK, Watson MJ, Cook DB, Kerr DN (1989) Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysis patients. Lancet ii:618–619Google Scholar
- Karacan I, Dervent A, Cunningham G (1978) Assessment of nocturnal penile tumescence as an objective method for evaluating sexual function in ESRD patients. Dialysis Transplant 7:872–875Google Scholar
- Mastrogiacomo I, Bonanni G, Gasparotto, Colonna A, Motta RG (1989) Semen analysis in hemo-dialysed and renal transplant patients. In: Seriom (ed) Proceedings of the 4th International Society of Andrology: miniposter 130. Serono Symposia review. Ares-Serono, RomeGoogle Scholar
- Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR (1963) Zinc metabolism in patients with the syndrome of iron deficiency anaemia, hepatosplenomegaly dwarfism and hypergonadism. J Clin Lab Med 61:537–549Google Scholar
- Randerson DH, Farrell PC (1981). Subjective assessment of CAPD patient. In Gahl GM et al. (eds) Advances in peritoneal dialysis. Excerpta Medica, Amsterdam pp 233–239Google Scholar
- Rodger RS, Fletcher K, Dewar JH, Genner D, McHugh M, Wilkinson R, Ward MK, Kerr DN (1985a) Prevalence and pathogenesis of impotence in one hundred uraemic men. Uraemia Invest 8:89–96Google Scholar
- Rodger RS, Fletcher K, Genner D, Dewar J, Ward MK, Kerr DNS (1986) Sexual dysfunction in patients treated by CAPD. In: Mehrer J, Winchester J (eds) Frontiers in peritoneal dialysis. Field Rich, New York, pp 512–515Google Scholar
- Wing AJ, Brunner FP, Brynger H et al. (1978) Combined report on regular dialysis and transplantation in Europe. Proc Euro Dial Transplant Assoc 15:3–76Google Scholar
- Zetin M, Frost NR, Brunsfield D, Stone RA (1987) Amitriptyline stimulates weight gain in haemodialysis patients. Clin Nephrol 18:79–82Google Scholar